AMPH Long Call Strategy

AMPH (Amphastar Pharmaceuticals, Inc.), in the Healthcare sector, (Drug Manufacturers - Specialty & Generic industry), listed on NASDAQ.

Amphastar Pharmaceuticals, Inc., established in 1996 and based in Rancho Cucamonga, California, functions as a biopharmaceutical enterprise. The company is engaged in the creation, production, commercialization, and distribution of both generic and proprietary pharmaceutical products, which include injectables, inhalants, and intranasal formulations. Its market presence extends across the United States, China, and France. Amphastar's operations are divided into two primary segments: Finished Pharmaceutical Products and Active Pharmaceutical Ingredients (API). The company's extensive product portfolio encompasses a variety of crucial medications. These feature Primatene Mist, an over-the-counter epinephrine inhaler for the temporary alleviation of mild asthma symptoms; Enoxaparin, a low molecular weight heparin utilized for the prevention and treatment of deep vein thrombosis; and Naloxone, an essential treatment for opioid overdose.

AMPH (Amphastar Pharmaceuticals, Inc.) trades in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a market capitalization of approximately $960.3M, a trailing P/E of 12.46, a beta of 0.90 versus the broader market, a 52-week range of 16.65-31.26, average daily share volume of 616K, a public-listing history dating back to 2014, approximately 2K full-time employees. These structural characteristics shape how AMPH stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.90 places AMPH roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.

What is a long call on AMPH?

A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.

Current AMPH snapshot

As of June 29, 2026, spot at $20.59, ATM IV 70.50%, IV rank 12.23%, expected move 20.21%. The long call on AMPH below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 18-day expiry.

Why this long call structure on AMPH specifically: AMPH IV at 70.50% is on the cheap side of its 1-year range, which favors premium-buying structures like a AMPH long call, with a market-implied 1-standard-deviation move of approximately 20.21% (roughly $4.16 on the underlying). The 18-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated AMPH expiries trade a higher absolute premium for lower per-day decay. Position sizing on AMPH should anchor to the underlying notional of $20.59 per share and to the trader's directional view on AMPH stock.

AMPH long call setup

The AMPH long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With AMPH near $20.59, the first option leg uses a $20.59 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed AMPH chain at a 18-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 AMPH shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Call$20.59N/A

AMPH long call risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.

AMPH long call payoff curve

Modeled P&L at expiration across a range of underlying prices for the long call on AMPH. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use long call on AMPH

Long calls on AMPH express a bullish thesis with defined risk; traders use them ahead of AMPH catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.

AMPH thesis for this long call

The market-implied 1-standard-deviation range for AMPH extends from approximately $16.43 on the downside to $24.75 on the upside. A AMPH long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current AMPH IV rank near 12.23% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on AMPH at 70.50%. As a Healthcare name, AMPH options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to AMPH-specific events.

AMPH long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. AMPH positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move AMPH alongside the broader basket even when AMPH-specific fundamentals are unchanged. Long-premium structures like a long call on AMPH are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current AMPH chain quotes before placing a trade.

Frequently asked questions

What is a long call on AMPH?
A long call on AMPH is the long call strategy applied to AMPH (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With AMPH stock trading near $20.59, the strikes shown on this page are snapped to the nearest listed AMPH chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are AMPH long call max profit and max loss calculated?
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the AMPH long call priced from the end-of-day chain at a 30-day expiry (ATM IV 70.50%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a AMPH long call?
The breakeven for the AMPH long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current AMPH market-implied 1-standard-deviation expected move is approximately 20.21%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long call on AMPH?
Long calls on AMPH express a bullish thesis with defined risk; traders use them ahead of AMPH catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
How does current AMPH implied volatility affect this long call?
AMPH ATM IV is at 70.50% with IV rank near 12.23%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

Related AMPH analysis